← All organizations
Highest phase reached
Phase 2
First clinical trial
Jan 1, 2019Last known activity
Jun 30, 2019
Timeline
2010s
- May 20, 2017
Destroy Pancreatic Cancer— Founded
Drugs by trial phase (4 distinct, 3 trials)
Phase 2 (4 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT03697239CollaboratorPhase 1/Phase 2Jun 30, 2019
- NCT03908333CollaboratorPhase 1/Phase 2May 1, 2019
- NCT03797443CollaboratorPhase 1/Phase 2Jan 1, 2019
Details
- Founded
- Atlanta, GA, US May 20, 2017
- Last known activity
- Jun 30, 2019